Drug prices: It’s time for change
The angry protests around the 2016 Mylan EpiPen scandal brought into focus the perils for patients when the price of a life-saving drug spikes precipitously. As a Type 1 diabetic who has been dealing with escalating insulin prices my whole life, I was heartened to see the outcry over our country’s anemic attitude toward setting affordable drug pricing policies. My concern now is that, without additional crises to capture the public’s attention, the issue will recede in significance. The realities for patients living under the price-spiral sword have not receded. Diabetics ...